No Data
Here's Why AcrobiosystemsLtd (SZSE:301080) Can Manage Its Debt Responsibly
Baipusais (301080.SZ): Expected net income in 2024 to decrease by 8.85%-21.87% year-on-year.
On January 16, Gelonghui announced that Baipusais (301080.SZ) expects its revenue for 2024 to be between 645 million yuan and -660 million yuan, an increase of 18.64% to 21.40% compared to the same period last year. Net income is expected to be between 120 million yuan and -140 million yuan, a decrease of 8.85% to 21.87% compared to the same period last year. The non-net profit is expected to be between 110 million yuan and -130 million yuan, a decrease of 7.41% to 21.65% compared to the same period last year. The company provides precise services for the biopharmaceutical and cellular immunotherapy industries.
Bepsyth: 2024 Annual Results Forecast
Baipusais (301080.SZ): A total of 0.1109% of shares have been repurchased.
On January 2, Gelonghui announced that by December 31, 2024, Baipusais (301080.SZ) had repurchased a total of 133,100 shares through a dedicated securities account for stock repurchase via centralized bidding, accounting for 0.1109% of the company's total share capital, with a highest Fill Price of 48.45 yuan/share, a lowest Fill Price of 41.82 yuan/share, and a total transaction amount of 5,995,950.50 yuan (excluding transaction fees).
Baipusais (301080.SZ): It is proposed to distribute a cash dividend of 3 yuan for every 10 shares in the first three quarters.
On December 30th, Gelonghui reported that Baipusais (301080.SZ) announced that the company decided to distribute profits to all shareholders and has proposed a profit distribution plan for the first three quarters of 2024. The specific details are as follows: based on the company's current total share capital of 120,000,000 shares, after excluding the 190,903 shares repurchased in the repurchase special securities account, the share capital is 119,809,097 shares. A cash dividend of 3.00 RMB (including tax) will be distributed for every 10 shares to all shareholders, totaling 35,942,729.10 RMB in cash dividends.
Is Acrobiosystems Co.,Ltd.'s (SZSE:301080) Recent Stock Performance Influenced By Its Fundamentals In Any Way?